Science & Enterprise subscription

Follow us on Twitter

  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 3 hours ago
  • New post on Science and Enterprise: NSF Funds AI Covid-19 Drug Combo Simulation https://t.co/j7DsIncCUk #Science #Business
    about 3 hours ago
  • A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for… https://t.co/CVwEr6dEoU
    about 4 hours ago
  • New post on Science and Enterprise: Gene-Edited Transplant Organ Company Raises $125M https://t.co/UYlUcA8Z5X #Science #Business
    about 8 hours ago
  • A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-1… https://t.co/82gYsU3rvr
    about 1 day ago

Please share Science & Enterprise

Gene-Edited Transplant Organ Company Raises $125M

Happy pig

A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for human transplantation. . . . → Read More: Gene-Edited Transplant Organ Company Raises $125M

Synthetic RNA Start-Up Gains $80M in Early Funds

RNA strand illustration

A start-up company, spun off from a biomedical engineering lab at MIT, is raising $80 million for therapies made from synthetic circular RNA. . . . → Read More: Synthetic RNA Start-Up Gains $80M in Early Funds

Gene-Editing Biotech Acquires DNA Bar Code Company

DNA chip graphic

A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes. . . . → Read More: Gene-Editing Biotech Acquires DNA Bar Code Company

ALS Trial Results Deemed Insufficient for FDA Approval

Neurons illustration

An ALS treatment developer says the Food and Drug Administration advised the company’s clinical trial data would likely not support approval for patient use. . . . → Read More: ALS Trial Results Deemed Insufficient for FDA Approval

FDA Issues Covid-19 Variant Regulatory Guidance

Covid-19 testing

Food and Drug Administration is updating its regulatory guidance for Covid-19 drugs and diagnostics to cover emerging mutations in the SARS-CoV-2 virus. . . . → Read More: FDA Issues Covid-19 Variant Regulatory Guidance

New Trial Testing Reformulated Covid-19 Vaccine

Panama City skyline

Two drug makers are beginning a clinical trial to test their reformulated vaccine against Covid-19 disease, particularly among older populations. . . . → Read More: New Trial Testing Reformulated Covid-19 Vaccine

Novavax Providing 1.1B Vaccine Doses to Global Group

Vaccine vials

Novavax, developer of a vaccine to prevent Covid-19 disease, is providing 1.1 billion doses of its vaccine for distribution to lower resource regions. . . . → Read More: Novavax Providing 1.1B Vaccine Doses to Global Group

Crispr-Edited Bananas Get Industry Funding

Cavendish bananas

A popular type of banana, genetically edited to resist a soil fungus that threatens this fruit worldwide, is now backed by a major American food brand. . . . → Read More: Crispr-Edited Bananas Get Industry Funding

Novartis, Gates Partner on Sickle Cell Gene Therapy

Gene therapy graphic

Global drug maker Novartis is collaborating with the Bill and Melinda Gates Foundation to find affordable gene therapies for sickle cell disease. . . . → Read More: Novartis, Gates Partner on Sickle Cell Gene Therapy

20 Precision Meds Approved by FDA in 2020

Syringe, pills, capsules

A report by a group advocating for precision medicine notes that the Food and Drug Administration approved 20 new personalized drugs and biologics in 2020. . . . → Read More: 20 Precision Meds Approved by FDA in 2020